Robotic carotid artery stenting: a multicenter, propensity score–matched analysis of clinical outcomes and cost-effectiveness

In the first multicenter study and largest sample to date, the authors show that robotic CAS, with a low rate of procedural failure and postoperative complications, is safe and feasible. In addition, robotic CAS achieves comparable clinical outcomes to manual CAS. Robotic CAS was associated with increased fluoroscopy time, but fluoroscopy time decreased as operators gained familiarity with the CorPath GRX system. Robotic CAS was associated with a greater procedural cost, which was driven by greater personnel and supply costs. Robotic CAS failed to show superiority to manual CAS. These findings set a foundation for randomized controlled trials of robotic CAS, and also highlight the need for further studies to optimize robotic CAS and reduce its associated costs.

Authors

Institutions

Publication Details

Journal
Neurosurgical FOCUS
Published
2024-12-01
DOI
https://doi.org/10.3171/2024.9.focus24479
Citations
4
Primary Topic
Cerebrovascular and Carotid Artery Diseases
Type
article
Field-Weighted Citation Impact
1.68
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Robotic carotid artery stenting: a multicenter, propensity score–matched analysis of clinical outcomes and cost-effectiveness

Antony A. Fuleihan, Visish Mani Srinivasan, Rawad Abbas, Shray Patel et al.
4 citations
Neurosurgical FOCUS
Cerebrovascular and Carotid Artery Diseases
1.68
article

Robotic carotid artery stenting: a multicenter, propensity score–matched analysis of clinical outcomes and cost-effectiveness

Antony A. Fuleihan, Visish Mani Srinivasan, Rawad Abbas, Shray Patel, Robert H. Rosenwasser, Pascal M. Jabbour, Kyle Scott, Joanna M. Roy, Michael Reid Gooch, Jan‐Karl Burkhardt, Basel Musmar, Advith Sarikonda, Ahilan Sivaganesan, Stavropoula I. Tjoumakaris
article en
4 citations

Abstract

In the first multicenter study and largest sample to date, the authors show that robotic CAS, with a low rate of procedural failure and postoperative complications, is safe and feasible. In addition, robotic CAS achieves comparable clinical outcomes to manual CAS. Robotic CAS was associated with increased fluoroscopy time, but fluoroscopy time decreased as operators gained familiarity with the CorPath GRX system. Robotic CAS was associated with a greater procedural cost, which was driven by greater personnel and supply costs. Robotic CAS failed to show superiority to manual CAS. These findings set a foundation for randomized controlled trials of robotic CAS, and also highlight the need for further studies to optimize robotic CAS and reduce its associated costs.

Neurosurgical FOCUSVol. 57(6)
Thomas Jefferson University (US), Thomas Jefferson University Hospital (US), WinnMed (US), Mayo Clinic in Florida (US), University of Pennsylvania (US)
Openalex Percentile: Top 14%
Cerebrovascular and Carotid Artery Diseases
1.68
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Robotic carotid artery stenting: a multicenter, propensity score–matched analysis of clinical outcomes and cost-effectiveness — Antony A. Fuleihan, Visish Mani Srinivasan, et al. · Neurosurgical FOCUS (2024) | TGRS Research Map | TGRS